VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 07, 2008) - Chemokine Therapeutics Corp. (the “Company”) (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced the financial and operating results of the year ended December 31, 2007.
